6 completed, 1 terminated. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 6, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
Follow MediGene: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating the Pharmacokinetic Profile of Novel Formulations of RHUDEX® RhuDex - Formulation Finding | Phase 1 | Completed | MediGene | 12 | 2011-12-01 | 2012-06-21 |
| Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers Veregen, Green Tea - Anogenital Warts | Phase 1 | Completed | MediGene | 30 | 2011-12-01 | 2012-04-19 |
| Study Evaluating the Pharmacokinetic Profile of RhuDex® in a Tablet Formulation RhuDex® - Pharmacokinetics | Phase 1 | Terminated | MediGene | 12 | 2008-05-01 | 2010-03-24 |
| Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex® RhuDex® - Pharmacokinetics | Phase 1 | Completed | MediGene | 10 | 2007-09-01 | 2008-07-16 |
| G207 Followed by Radiation Therapy in Malignant Glioma G207 - Malignant Glioma | Phase 1 | Completed | MediGene | 9 | 2005-05-01 | 2008-12-16 |
| Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver NV1020 - Colorectal Cancer, Liver Neoplasms | Phase 1 / Phase 2 | Completed | MediGene | 32 | 2004-07-01 | 2018-04-24 |
| Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer G207, an oncolytic virus - Glioma, Astrocytoma | Phase 1 / Phase 2 | Completed | MediGene | 65 | 2001-12-01 | 2005-06-24 |
Astrocytoma (2) · Brain Neoplasms (2) · Glioblastoma (2) · Glioma (2) · Arthritis, Rheumatoid (1) · Carcinoma, Hepatocellular (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Condylomata Acuminata (1) · Gliosarcoma (1) · Liver Neoplasms (1) · Rectal Neoplasms (1) · Recurrence (1)
Tea (1) · green tea extract polyphenone E (1)
United Kingdom (3) · United States (2) · Germany (1)
Axel Mescheder, M.D. (1) · Hoda Tawfik, PhD (1) · Stephen Freestone, MD (1) · Stuart Mair, MBChB, DROCG,DCPSA (1)